BIND THERAPEUTICS INC
BIND
BIND was delisted on the 29th of July, 2016.
5 hedge funds and large institutions have $14.7M invested in BIND THERAPEUTICS INC in 2013 Q3 according to their latest regulatory filings, with 5 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCPEM
Bain Capital Public Equity Management
Boston,
Massachusetts
|
+$6.48M |
| 2 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
+$3.03M |
| 3 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
+$2.18M |
| 4 |
WSA
Wall Street Associates
Lajolla,
California
|
+$1.8M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$1.48M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BCPEM
1
Bain Capital Public Equity Management
Boston,
Massachusetts
| $6.35M | +$6.48M | +450,000 | New |
|
|
EA
2
Emerald Advisers
Leola,
Pennsylvania
| $2.97M | +$3.03M | +210,140 | New |
|
|
EMFAT
3
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
| $2.14M | +$2.18M | +151,490 | New |
|
|
WSA
4
Wall Street Associates
Lajolla,
California
| $1.76M | +$1.8M | +125,000 | New |
|
|
5
Alyeska Investment Group
Chicago,
Illinois
| $1.45M | +$1.48M | +102,500 | New |
|
BIND Hedge Fund Activity: Q3 2013 in Review
5 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in BIND THERAPEUTICS INC (BIND) for Q3 2013, worth a combined $14.7M.
Buyers outnumbered sellers: 5 funds opened new BIND positions and 0 closed out — a net gain of 5 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Bain Capital Public Equity Management, opening a new position worth an estimated $6.48M.
- 5 institutional investors held BIND THERAPEUTICS INC (BIND) as of Q3 2013, up from 0 in Q2 2013.
- Funds reported $14.7M of BIND THERAPEUTICS INC stock for Q3 2013.
- 5 funds opened new BIND THERAPEUTICS INC positions in Q3 2013 and 0 closed out, a net change of +5 holders.
- The largest BIND THERAPEUTICS INC buyer in Q3 2013 was Bain Capital Public Equity Management, an estimated $6.48M added.
Based on aggregated 13F filings for Q3 2013.